Merck Canada

Merck Canada company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For over 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities. This page is intended for the residents of Canada. Read our Community Engagement Guidelines, visit https://bit.ly/49Cfz86

Company Details

Employees
259
Address
16750 Trans-Canada Hwy, Kirkland,quebec H9h 4m7,canada
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Kirkland, Quebec
Looking for a particular Merck Canada employee's phone or email?

Merck Canada Questions

News

Young B.C. melanoma survivor talks about staying 'sun safe' outdoors | Lifestyle - Daily Hive Vancouver

Young B.C. melanoma survivor talks about staying 'sun safe' outdoors | Lifestyle Daily Hive Vancouver

HEALTH CANADA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-release Injectable Suspension) from Merck Animal Health - Yahoo Finance

HEALTH CANADA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-release Injectable Suspension) from Merck Animal Health Yahoo Finance

Merck Moves Forward in Bid To Bring First Oral PCSK9 Inhibitor to Market - BioSpace

Merck Moves Forward in Bid To Bring First Oral PCSK9 Inhibitor to Market BioSpace

Health Canada Approves KEYTRUDA® for Patients with Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma Tumours that are PD-L1 (CPS) Positive as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiothera - PR Newswire Canada

Health Canada Approves KEYTRUDA® for Patients with Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma Tumours that are PD-L1 (CPS) Positive as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiothera PR Newswire Canada

Closing the Gaps: Merck Canada Introduces New Leadership - Canadian Business

Closing the Gaps: Merck Canada Introduces New Leadership Canadian Business

Merck, plaintiff agree to hit the brakes on Gardasil trial in California - Fierce Pharma

Merck, plaintiff agree to hit the brakes on Gardasil trial in California Fierce Pharma

Health Canada Approves KEYTRUDA® for the treatment of adult patients with FIGO 2014 Stage III-IVA cervical cancer, in combination with chemoradiotherapy (CRT)¹ - Yahoo Finance

Health Canada Approves KEYTRUDA® for the treatment of adult patients with FIGO 2014 Stage III-IVA cervical cancer, in combination with chemoradiotherapy (CRT)¹ Yahoo Finance

Merck Animal Health hiring for various positions - The Employment Journey

Merck Animal Health hiring for various positions The Employment Journey

Pride Toronto says it's lost 2 more sponsors ahead of annual 2SLGBTQ+ festival - CBC

Pride Toronto says it's lost 2 more sponsors ahead of annual 2SLGBTQ+ festival CBC

Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant tre - Yahoo Finance

Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant tre Yahoo Finance

Merck boosts viral vectors in California - Chemical & Engineering News

Merck boosts viral vectors in California Chemical & Engineering News

Merck KGaA to spend $110M on new gene therapy facility in California - BioPharma Dive

Merck KGaA to spend $110M on new gene therapy facility in California BioPharma Dive

Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) - Yahoo Finance

Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) Yahoo Finance

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M - BioSpace

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M BioSpace

As Exclusivity Loss Looms, Merck Wins Subcutaneous Approval for Keytruda - BioSpace

As Exclusivity Loss Looms, Merck Wins Subcutaneous Approval for Keytruda BioSpace

Keytruda Redeems Itself in Head and Neck Cancer as Merck Lands Potential $1.9B I&I Collab - BioSpace

Keytruda Redeems Itself in Head and Neck Cancer as Merck Lands Potential $1.9B I&I Collab BioSpace

Exclusive-Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial - Yahoo

Exclusive-Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial Yahoo

Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal - BioSpace

Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal BioSpace

Merck opens $1 billion addition in north Durham to boost production of popular vaccine - Yahoo

Merck opens $1 billion addition in north Durham to boost production of popular vaccine Yahoo

Merck to acquire Verona Pharma for $10 billion - Yahoo

Merck to acquire Verona Pharma for $10 billion Yahoo

Merck prevails in US safety litigation over Gardasil HPV vaccine - Yahoo

Merck prevails in US safety litigation over Gardasil HPV vaccine Yahoo

Merck Canada awards $4 M to Faculty of Medicine - McGill University

Merck Canada awards $4 M to Faculty of Medicine McGill University

Danell Merck Obituary (2022) - Lodi, CA - Lodi-News Sentinel - Legacy obituary

Danell Merck Obituary (2022) - Lodi, CA - Lodi-News Sentinel Legacy obituary

DAVID D. JONES IS APPOINTED AS PRESIDENT AND MANAGING DIRECTOR OF MERCK CANADA - PR Newswire Canada

DAVID D. JONES IS APPOINTED AS PRESIDENT AND MANAGING DIRECTOR OF MERCK CANADA PR Newswire Canada

U of T and Merck Canada partner to advance and share vaccine knowledge and research - Defy Gravity Campaign

U of T and Merck Canada partner to advance and share vaccine knowledge and research Defy Gravity Campaign

Merck says experimental drug molnupiravir cuts worst effects of COVID-19 - CBC

Merck says experimental drug molnupiravir cuts worst effects of COVID-19 CBC

Layoff Tracker: Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure - BioSpace

Layoff Tracker: Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure BioSpace

Merck (MRK) Gains FDA Priority Review for Keytruda in Bladder Ca - GuruFocus

Merck (MRK) Gains FDA Priority Review for Keytruda in Bladder Ca GuruFocus

MERCK CANADA ANNOUNCES COLLABORATION WITH VECTOR INSTITUTE TO FURTHER ADVANCE ITS ARTIFICIAL INTELLIGENCE CAPABILITIES AND DRIVE INNOVATION IN HEALTHCARE - PR Newswire Canada

MERCK CANADA ANNOUNCES COLLABORATION WITH VECTOR INSTITUTE TO FURTHER ADVANCE ITS ARTIFICIAL INTELLIGENCE CAPABILITIES AND DRIVE INNOVATION IN HEALTHCARE PR Newswire Canada

Merck to make its COVID-19 antiviral pill in Canada, company announces - Global News

Merck to make its COVID-19 antiviral pill in Canada, company announces Global News

WINREVAIR® (sotatercept) is now authorized for use in Canada for Adults with Pulmonary Arterial Hypertension - PR Newswire Canada

WINREVAIR® (sotatercept) is now authorized for use in Canada for Adults with Pulmonary Arterial Hypertension PR Newswire Canada

What's happening with antiviral drugs to treat COVID-19? - CBC

What's happening with antiviral drugs to treat COVID-19? CBC

Merck agrees to let other drugmakers produce its COVID-19 pill - CBC

Merck agrees to let other drugmakers produce its COVID-19 pill CBC

New mobile application for veterinarians and producers takes the guesswork out of deworming cattle - Ag Proud

New mobile application for veterinarians and producers takes the guesswork out of deworming cattle Ag Proud

Merck's HPV Vaccine, GARDASIL®9, now available in Canada - PR Newswire

Merck's HPV Vaccine, GARDASIL®9, now available in Canada PR Newswire

As national measles vaccine shortage extends another month, some travel to U.S. - CBC

As national measles vaccine shortage extends another month, some travel to U.S. CBC

A talk with Merck Mercuriadis, the Canadian spending billions on acquiring song catalogues - Global News

A talk with Merck Mercuriadis, the Canadian spending billions on acquiring song catalogues Global News

Canada faces shortage of measles vaccines amid rise in cases, demand - CBC

Canada faces shortage of measles vaccines amid rise in cases, demand CBC

'Playing in the big leagues': P.E.I. fish health company sells for $1.3 billion - CBC

'Playing in the big leagues': P.E.I. fish health company sells for $1.3 billion CBC

Anil Maharaj wins Merck Canada Ltd. Postgraduate Pharmacy Fellowship Award - University of Waterloo

Anil Maharaj wins Merck Canada Ltd. Postgraduate Pharmacy Fellowship Award University of Waterloo

Hair loss drug finasteride can cause debilitating side-effects, men say - CBC

Hair loss drug finasteride can cause debilitating side-effects, men say CBC

Merck Canada awards $4M to Faculty of Medicine - McGill Reporter

Merck Canada awards $4M to Faculty of Medicine McGill Reporter

Pfizer, Merck press ahead with pills to treat COVID-19 - Global News

Pfizer, Merck press ahead with pills to treat COVID-19 Global News

Merck Has Some Explaining To Do Over Its MMR Vaccine Claims - HuffPost

Merck Has Some Explaining To Do Over Its MMR Vaccine Claims HuffPost

Engemycin DD approved by Health Canada - Manitoba Co-operator

Engemycin DD approved by Health Canada Manitoba Co-operator

Paul MacDonald's Top Picks: Merck, Abbvie and UnitedHealth Group - BNN Bloomberg

Paul MacDonald's Top Picks: Merck, Abbvie and UnitedHealth Group BNN Bloomberg

Suspicious fire at Merck Kirkland office - CityNews Montreal

Suspicious fire at Merck Kirkland office CityNews Montreal

Whitby’s Thermo Fisher Scientific plant ready to begin supplying Molnupiravir upon approval, Merck says - Global News

Whitby’s Thermo Fisher Scientific plant ready to begin supplying Molnupiravir upon approval, Merck says Global News

Indigenous Researchers Receive $2.6 Million Funding From Merck Canada Inc. for Indigenous Maternal and Child Health Program in Ontario - PR Newswire Canada

Indigenous Researchers Receive $2.6 Million Funding From Merck Canada Inc. for Indigenous Maternal and Child Health Program in Ontario PR Newswire Canada

Merck Canada Appoints David D. Jones As New President And Managing Director - Canadian Manufacturing

Merck Canada Appoints David D. Jones As New President And Managing Director Canadian Manufacturing

'This information is useless': Drug companies reveal they paid millions to doctors but don't say why | CBC News - CBC

'This information is useless': Drug companies reveal they paid millions to doctors but don't say why | CBC News CBC

Merck Mercuriadis - Catalyst for Change - Cashbox Canada

Merck Mercuriadis - Catalyst for Change Cashbox Canada

Merck to begin manufacturing COVID-19 antiviral pills in Whitby, Ont. - Global News

Merck to begin manufacturing COVID-19 antiviral pills in Whitby, Ont. Global News

Merck Canada working hands-on to advance maternal health as part of Community Action Day - PR Newswire Canada

Merck Canada working hands-on to advance maternal health as part of Community Action Day PR Newswire Canada

Merck Receives Approval of ZEPATIER™ (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review - PR Newswire Canada

Merck Receives Approval of ZEPATIER™ (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review PR Newswire Canada

Health Canada Approves GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the Prevention of Oropharyngeal and Other Head and Neck Cancers - PR Newswire Canada

Health Canada Approves GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the Prevention of Oropharyngeal and Other Head and Neck Cancers PR Newswire Canada

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis - CMAJ

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis CMAJ

Merck's HPV Vaccine, GARDASIL®9, now available in Canada - PR Newswire Canada

Merck's HPV Vaccine, GARDASIL®9, now available in Canada PR Newswire Canada

Merck says experimental drug molnupiravir cuts worst effects of COVID-19 - Radio-Canada

Merck says experimental drug molnupiravir cuts worst effects of COVID-19 Radio-Canada

Marvelon 28 birth control pills missing day label stickers, Health Canada says - CBC

Marvelon 28 birth control pills missing day label stickers, Health Canada says CBC

Vioxx settlement to cost Merck up to $37M US - CBC

Vioxx settlement to cost Merck up to $37M US CBC

Quebec Merck closure could mean ‘brain drain’ - CBC

Quebec Merck closure could mean ‘brain drain’ CBC

Top Merck Canada Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant